PROM1 and hepatocellular carcinoma: In this paper, we show that CD133-positive HCC cells exhibit strong resistance to reactive oxygen species (ROS) via upregulation of glutathione (GSH) levels, and thereby play a central role in resistance to liver cancer therapy.